Fundraising FoxLifeforce Capital — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
Fauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans.
AI & Machine LearningBiotechDeep TechHealthtechEmeryville, US
Linda Goodman(Founder)inAshley(CEO)
Co-investorsage1Farvatn VentureGaingelsGRIDS CapitalLifespan Vision VenturesMetaplanet+8 more
__Twitter.png)
Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Aaron Morris(Founder)inAlpha Lee(Chief Scientific Officer)inMatthew Robinson(Founder)inMatt Robinson(Founder)Milan Cvitkovic(ML Researcher)Ruby Pai(ML Researcher)
Co-investorsBreyer CapitalHOF CapitalMetaplanetPioneerY CombinatorACE & Company+2 more
Sempre Health provides digital health solutions focused on patient engagement and outcomes management for the healthcare industry.
Digital HealthHealthtechSan Francisco, US
Anurati Mathur(Founder)inSwaraj Banerjee(Founder)inRobert S. Spalding(Executive Officer, Director)Ashley Carroll(Director)
BoardJenny Abramson(Director)inTyler Rowe(Director)
Co-investorsBlue Venture FundsCencora VenturesCerity Partners VenturesEcho Health VenturesRethink ImpactSterling Road+4 more
Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Jeffrey Bluestone(Founder)inJeff Bluestone, PhD(Founder and Scientific Advisor; co-founder and former President and CEO)Qizhi Tang, PhD(Founder and Scientific Advisor)Fred Ramsdell, PhD(Founder and Scientific Advisor)Alexander Rudensky, PhD(Founder and Scientific Advisor)Stephen Dilly, MBBS, PhD(President and Chief Executive Officer)
Co-investors8VCARCH Venture PartnersFrazier Life SciencesGV (Google Ventures)JDRF T1D FundLAV+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.